SCHEMBL5014652

SCHEMBL5014652

N=C(c1ccc(Br)cc1)C(F)(F)F.O=C(c1ccc(Br)cc1)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.48
CES2 O00748 1/20 0.43
MLYCD O95822 10/20 0.42
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
TRPV1 Q8NER1 1/20 0.39
GSK3B P49841 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516554 0.88 CES2 (0.42) CES1CES2LMNAHSP90AA1MAPT
SCHEMBL17216 0.88 CES1 (0.60) CES1CES2MLYCDLMNAHSP90AA1
SCHEMBL29137293 0.76 CES1 (0.54) CES1CES2LMNAHSP90AA1MAPT
SCHEMBL29035984 0.76 CES1 (0.54) CES1CES2LMNAHSP90AA1MAPT
SCHEMBL20640032 0.74 MLYCD (0.50) CES1MLYCDLMNAHSP90AA1MAPT
SCHEMBL1421656 0.73 CES1 (0.70) CES1MLYCDCA1CA2HDAC1
SCHEMBL4490669 0.73 CES1 (0.43) CES1CES2MLYCDLMNAHSP90AA1
SCHEMBL4656447 0.73 CES2 (0.62) CES1CES2LMNAMAPTTDP1
SCHEMBL28906999 0.72 CES1 (0.50) CES1CES2LMNAHSP90AA1MAPT
SCHEMBL7958861 0.72 CES1 (0.50) CES1CES2LMNAHSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893562-A1 REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE A AND B Merck Frosst Canada Ltd. (CA) 2008-03-05 EP disclosed
WO-2006133559-A1 REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE A AND B MERCK FROSST CANADA LTD. (CA) 2006-12-21 WO disclosed